Open Label, Nonrandomized Clinical Trial of Safety and Tolerability of Enfuviritide (Fuzeon, HIV Fusion Inhibitor) in Patients With Advanced HIV1 Infection

Trial Profile

Open Label, Nonrandomized Clinical Trial of Safety and Tolerability of Enfuviritide (Fuzeon, HIV Fusion Inhibitor) in Patients With Advanced HIV1 Infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Enfuvirtide (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 02 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top